William Roberts, VP Regulatory Development and at REGENERON PHARMACEUTICALS INC (REGN), sold 18,500 shares at $144.00 ($2.2M) on 2012-08-23, disclosed to the SEC on 2012-08-27.
Scheduled sale ($2.2M) by VP Regulatory Development and under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $144.00 | 15,000 | $2.2M | 100.0% |
| 2 | $0.00 | 3,500 | $0 | 0.0% |
| Total | $116.76 avg | 18,500 | $2.2M | 100% |
| Filing → |
| REGN | SELL | 2012-01-11 | $2.4M | — | Filing → |
| REGN | SELL | 2011-09-08 | $1.5M | — | Filing → |
| REGN | SELL | 2011-07-18 | $6K | — | Filing → |